Acute myeloid leukemia patients oral targeted drug Vinaikra effect time is related to the patient’s drug sensitivity and individual differences, there is no definite time point, according to the drug metabolism, generally in 2~3 days after taking the drug to achieve effective blood concentration, play a role in the therapeutic effect.
Vinacrine Tablets are to be used in combination with Azacitidine for the treatment of newly diagnosed adult acute myeloid leukemia patients who are unsuitable for strong induction chemotherapy due to comorbidities, or who are over 75 years of age. It is used in combination with azacitidine according to the course of treatment, and the effective dose is usually achieved in 2 to 3 days until disease progression or intolerable toxic reactions occur.
There are no clear contraindications to the use of Venekra Tablets, but the instructions should be followed. Adverse reactions such as nausea, diarrhea, constipation, neutropenia, thrombocytopenia, hemorrhage, peripheral edema, vomiting, fatigue, febrile neutropenia, rash, and anemia may occur after administration of this drug. It should be used with caution in patients with tumor lysis syndrome and neutropenia.
Vinaclat Tablet is an anti-tumor drug and should be used with caution under professional medical supervision. If there is any abnormality, it is necessary to go to the hospital for examination and treatment under doctor’s guidance.